CS logo
small CS logo
Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center

Los Angeles, California, United States
Cancer treatment center in Los Angeles, California
127 S San Vicente Blvd, Los Angeles, CA 90048

About Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
Children's Oncology Group
21
Alliance for Clinical Trials in Oncology
17
Pfizer
12
Seagen Inc.
5
Radiation Therapy Oncology Group
4
Cedars-Sinai Medical Center
3
SWOG Cancer Research Network
3
Aptium Oncology Research Network
2
CancerVax Corporation
2
Eastern Cooperative Oncology Group
2
Favrille
2
Total Rows: 50

Clinical Trials at Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center


During the past decade, Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 28 clinical trials were completed, i.e. on average, 107.7% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 7 clinical trials were completed. i.e. 63.6% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years11444455113377001144221010332233220022Started TrialsCompleted Trails201520162017201820192020202120222023051015
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy in Treating Children With Progressive Brain Tumors
1997-04-01
2012-04-01
Completed
428
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Newly Diagnosed Rhabdomyosarcoma
1997-08-01
2011-01-01
Completed
483
Combination Chemotherapy in Treating Children With Neuroblastoma
1988-03-01
2011-01-01
Completed
573
Gene Testing to Help in the Diagnosis and Treatment of Childhood Brain Tumors
1996-12-01
2007-03-01
Completed
88
Surgery in Treating Children With Neuroblastoma
1998-03-01
2006-03-01
Completed
968
Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Infants With Malignant Brain or Spinal Cord Tumors
1998-03-01
2011-10-01
Completed
94
Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome
1999-06-01
2012-04-01
Completed
254
Fludarabine With or Without Cyclophosphamide in Treating Patients With Chronic Lymphocytic Leukemia
1999-12-01
Completed
280

Rows per page:

1–100 of 117

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center" #1 sponsor was "Children's Oncology Group" with 21 trials, followed by "Alliance for Clinical Trials in Oncology" with 17 trials sponsored, "Pfizer" with 12 trials sponsored, "Seagen Inc." with 5 trials sponsored and "Radiation Therapy Oncology Group" with 5 trials sponsored. Other sponsors include 53 different institutions and companies that sponsored additional 50 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 55 trials as a collaborator, "Cancer and Leukemia Group B" with 5 trials as a collaborator, "NRG Oncology" with 4 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator and "Merck Sharp & Dohme LLC" with 3 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 28 trials.
Created with Highcharts 11.1.0Top Leading SponsorsChildren's Oncology Group: 21Children's Oncology Group: 21Alliance for ClinicalTrials in Oncology: 17Alliance for ClinicalTrials in Oncology: 17Pfizer: 12Pfizer: 12Seagen Inc.: 5Seagen Inc.: 5Radiation TherapyOncology Group: 4Radiation TherapyOncology Group: 4Cedars-Sinai Medical Center: 3Cedars-Sinai Medical Center: 3SWOG Cancer ResearchNetwork: 3SWOG Cancer ResearchNetwork: 3Aptium OncologyResearch Network: 2Aptium OncologyResearch Network: 2CancerVax Corporation: 2CancerVax Corporation: 2Eastern CooperativeOncology Group: 2Eastern CooperativeOncology Group: 2

Created with Highcharts 11.1.0Top CollaboratorsNational CancerInstitute (NCI): 55National CancerInstitute (NCI): 55Cancer and LeukemiaGroup B: 5Cancer and LeukemiaGroup B: 5NRG Oncology: 4NRG Oncology: 4SWOG Cancer ResearchNetwork: 4SWOG Cancer ResearchNetwork: 4Merck Sharp & Dohme LLC: 3Merck Sharp & Dohme LLC: 3Bristol-Myers Squibb: 2Bristol-Myers Squibb: 2Eli Lilly and Company: 2Eli Lilly and Company: 2ICON plc: 2ICON plc: 2Merck KGaA,Darmstadt, Germany: 2Merck KGaA,Darmstadt, Germany: 2Abbott: 1Abbott: 1

Clinical Trials Conditions at Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center


According to Clinical.Site data, the most researched conditions in "Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center" are "Lung Cancer" (13 trials), "Leukemia" (9 trials), "Prostate Cancer" (8 trials), "Breast Cancer" (7 trials) and "Lymphoma" (7 trials). Many other conditions were trialed in "Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center" in a lesser frequency.

Clinical Trials Intervention Types at Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center


Most popular intervention types in "Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center" are "Drug" (97 trials), "Biological" (23 trials), "Radiation" (19 trials), "Procedure" (14 trials) and "Other" (11 trials). Other intervention types were less common.
The name of intervention was led by "cyclophosphamide" (16 trials), "radiation therapy" (14 trials), "carboplatin" (12 trials), "etoposide" (11 trials) and "filgrastim" (11 trials). Other intervention names were less common.

Clinical Trials Genders at Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center


The vast majority of trials in "Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center" are 97 trials for "All" genders, 12 trials for "Female" genders and 8 trials for "Male" genders.

Clinical Trials Status at Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center


Currently, there are NaN active trials in "Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center". 1 are not yet recruiting, 10 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 75 completed trials in Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, undefined suspended trials, and 15 terminated clinical trials to date.
Out of the total trials that were conducted in Samuel Oschin Comprehensive Cancer Institute at Cedars-Sinai Medical Center, 25 "Phase 1" clinical trials were conducted, 52 "Phase 2" clinical trials and 43 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 2: 52Phase 2: 52Phase 3: 43Phase 3: 43Phase 1: 25Phase 1: 25Not Applicable: 4Not Applicable: 4

Created with Highcharts 11.1.0Trials StatusCompleted: 75Completed: 75Terminated: 15Terminated: 15Recruiting: 10Recruiting: 10Unknown status: 8Unknown status: 8Active, not recruiting: 7Active, not recruiting: 7Not yet recruiting: 1Not yet recruiting: 1Withdrawn: 1Withdrawn: 1